GUTS - Fractyl Health Inc. Qarzning balans kapitallashuviga nisbati

Fractyl Health Inc. (GUTS) grafik logotipi

Global logistika va sanksiyalar xatarlari Fractyl Health, Inc. (GUTS) rivojlanishiga to'sqinlik qilishi mumkin. Biroq, diabetni davolash uchun endoskopiyadagi innovatsiyalar shifokorlarning ishonchini kuchaytirmoqda. Kompaniyaning balans kapitaliga nisbatan qarz yuklamasi ushbu muvozanatni aks ettiradi, bunda 0.00 qiymati ushbu holatni ko'rsatadi. Ilmiy progressga qaramay, barqaror operatsion pul oqimi hali shakllanmaganligi sababli, biznes rezervlarga tayanmoqda.

GUTS (Fractyl Health, Inc) Qarzning balans qiymatiga nisbati tarixi 21.02.2024dan 28.10.2026gacha
Fractyl asosiy tovari

Ushbu ko'rsatkich biznesning o'z balansidagi kapitaliga nisbatan qarz kapitaliga bog'liqlik darajasini belgilaydi. Hisob-kitob qarz majburiyatlarining sof aktivlar qiymatiga nisbatini aks ettirib, emitentning moliyaviy barqarorligini o'lchaydi. Qarzning kapitalizatsiyaga nisbati ko'rsatkichlari tarixini tahlil qilish orqali investor to'lov qobiliyatining yo'qligi riskini baholaydi. Fractyl Health, Inc. (GUTS) uchun bu juda muhimdir, chunki sog'liqni saqlash gigantlarining diabet terapiyasi sohasidagi agressiv kengayishi ulkan resurslarni talab qiladi. Bu yerda kreditlar va kapital o'rtasidagi muvozanat kompaniyaning shiddatli raqobat muhitida omon qolish qobiliyatini belgilaydi.

Fractyl Health, Inc. (GUTS) raqobatchilari

Balans kapitallashuviga qarzlar ASND (Ascendis Pharma A/S)|madrigalpharma.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Corcept Therapeutics Incorporated (CORT)|RYTM: Qarzning sof aktivlarga nisbati|AKRO (Akero Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Metsera Therapeutics (MTSR) - Qarzning balans qiymatiga nisbati|MLTX (MoonLake Immunotherapeutics) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar crinetics.com (CRNX)|NewAmsterdam Pharma Company N.V. (NAMS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati SLNO (Soleno Therapeutics Inc)|Amicus Pharma - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati 89bio Pharma ETNB|AGIO (Agios Pharmaceuticals) - Balans kapitallashuviga qarzlar|structuretx.com (GPCR) - Balans qiymatiga qarzlar|MDXG - Qarzning balans qiymatiga nisbati|Rezolute Inc (RZLT) - Qarzning balans kapitaliga nisbati|LXRX (Lexicon Pharma) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar MBX Corp|Balans kapitallashuviga qarzlar Altimmune, Inc. (ALT)|Qarzning balans kapitallashuviga nisbati AARD (aardvarktherapeutics.com)|SGMT: Qarzning balans kapitallashuviga nisbati|BioAge Labs - Balans qiymatiga qarzlar|BMEA - Qarzning balans kapitallashuviga nisbati|QNCX - Qarzning balans kapitallashuviga nisbati|vtvtherapeutics.com - Balans kapitallashuviga qarzlar|ATPC (Agape ATP) - Sof aktivlarga qarzlar|PLUR: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar SYBX|Qarzning balans kapitallashuviga nisbati LPCN (Lipocine Corp)|Qarzning balans qiymatiga nisbati matinasbiopharma.com (MTNB)|Spruce Biosciences, Inc. (SPRB) - Balans kapitallashuviga qarzlar|galecto.com - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Carmell (CTCX)|LUMO - Qarzning sof aktivlarga nisbati|ONVO: Balans kapitallashuviga qarzlar|Radius Pharmaceuticals (RDUS) - Balans kapitallashuviga qarzlar